Published 2 September 2026 · Reviewed by Dr Sin Yong
The fullness under a chin looks like one problem and is at least four: fat, gland, muscle and skin — with the chin itself sometimes an accomplice. They photograph the same. They are treated completely differently. Which is why the first appointment should be an identification, not a procedure.

“Double chin” is a description of a silhouette, not a diagnosis. Under that silhouette I regularly find four distinct anatomical situations, alone or in combination. The first is genuine submental fat — a discrete compartment of fat beneath the chin, part of it above the platysma muscle and part below it. This is the version everyone assumes they have.
The second is the submandibular glands: paired salivary glands tucked under the jawline. They are normal anatomy, but when they are naturally prominent, or when they descend with age, they present as fullness just behind the jaw that no diet and no fat treatment will touch. The third is the platysma itself — the thin muscle sheet of the neck. When its tone and support go, the tissues it was holding drape downward and the crisp angle between jaw and neck softens into a slope.
The fourth is skin. Dermal collagen and elastin decline with age, and skin that has lost its recoil gathers under the chin as laxity — a fold made of envelope, not contents. Four situations, one shadow. And a fifth factor sits behind them all: the skeleton they hang from.
The most persistent myth in this area is that a double chin is a weight problem. Plenty of lean patients sit in my chair with a soft submental fold, having tried to exercise away something that was never fat. Submental fullness has a genetic component — some people store fat preferentially there at any body weight — and gland prominence, muscle laxity and skin quality have nothing to do with the bathroom scale at all.
Chin projection matters more than almost anyone expects. A chin that sits slightly recessed shortens the visible jawline and deepens the shadow beneath it; modest fullness that a projected chin would carry invisibly becomes a fold. In these faces the honest conversation is about support and structure — territory covered in my face slimming guide — rather than about removing anything.
Posture writes itself into the picture too. Hours of chin-down time over phones and desks compress the submental tissues and rehearse the fold, which is also why so many people first notice the problem in the front camera — a lens held low, at the exact angle that exaggerates it. None of this means posture caused the anatomy. It means the photograph that alarmed you is not an examination.
“You can be lean and still have a double chin.”
Dr Sin YongOn fat, glands, muscle and skin
Every popular double chin treatment is aimed at exactly one of the four tissues. Cooling-based fat treatments injure fat cells selectively. Deoxycholic acid — the injectable studied in the REFINE trials — works by disrupting the fat-cell membrane so the adipocyte breaks down. Both are mechanisms specific to fat. Aim either at a fold made of lax skin, a descended gland or a slack platysma and the mechanism has nothing to act on.
Worse than doing nothing, a fat treatment applied to the wrong problem can subtract the one thing propping the area up. Remove fat from under skin that has already lost its recoil and the deflated envelope can hang more visibly than before — the fold softens in volume and worsens in drape. The patient concludes the treatment failed; in truth the diagnosis did.
The reverse mismatch wastes effort in the other direction: energy-based skin tightening pointed at a genuinely fatty compartment tightens the envelope around contents that were the actual problem. Skin laxity responds to energy devices; fat responds to fat-directed treatment; the platysma and the glands are their own conversations entirely. This is why the double chin treatment page reads as a set of different tools rather than one flagship machine — the tool follows the tissue.
The examination is physical and unhurried. Pinching the submental tissue between the fingers separates what is graspable fat from what is loose envelope. Asking you to tense the neck — gritting the teeth activates the platysma — shows what the muscle is still doing and what changes when it engages. Palpation just under the jawline distinguishes the firm, discrete character of a gland from the softness of fat. The profile is studied for chin projection, and the whole area is watched in animation and in different head positions, because a fold that vanishes when you look up is telling you something about posture and skin that a static photo cannot.
Most patients turn out to have a combination — commonly some fat plus some laxity, in proportions that decide which is addressed first and whether both need addressing at all. Sequencing built on that examination is the difference between a plan and a purchase.
This is the reasoning behind assessing the lower face as structure rather than as a menu of areas, which is how my private aesthetics analysis approaches it: identify the tissue responsible, then — and only then — discuss what acts on that tissue.
Chin and jawline pages are usually built on photo pairs, so their absence here deserves a direct answer.
Under Singapore’s Healthcare Services Act, before-and-after imagery in advertising for licensable healthcare services is prohibited. No consent form or disclaimer creates an exemption, and after-only images fall under the same rule. This applies identically to every licensed clinic in Singapore — a site displaying such images is not demonstrating better results, only weaker compliance.
It is also, for this particular problem, a rule that protects you: a photo pair cannot show you which of the four causes the pictured chin had, and yours may share none of them. The useful comparison is your own anatomy, examined in person.
Prices for licensable healthcare services cannot be advertised in Singapore, including as ranges or “from” figures. What can be set out is what the cost depends on.
The factors are what the examination identifies as the responsible tissue or combination, whether a single modality is indicated or several in sequence, the size of the area being addressed, and how the plan is staged over time. A small, purely fatty compartment and a combination of laxity, muscle and projection are entirely different undertakings. Fees are set out in full at consultation, once there is a specific plan to cost.
A double chin is one of the easiest problems in aesthetics to treat wrongly, because the wrong treatment is usually a perfectly good treatment — for a different tissue. Fat-directed methods are legitimate; so is skin tightening; so is work on structure and support. What is not legitimate is choosing between them from a photograph or a promotion.
So the sequence here is deliberately unexciting: examine, identify, and match the treatment to the tissue — or say plainly that the main contributor is skeletal or postural and reframe the conversation. I assess the submental area personally at Orchard Road, and if what you have is not what you assumed, you will hear it before anything is planned.
Submental fullness in lean people usually comes from genetically stored fat in the submental compartment, prominent or descended submandibular glands, laxity of the platysma muscle or the skin, or a chin that sits slightly recessed and deepens the shadow beneath the jaw. Body weight is only one contributor among several, which is why the cause is identified by examination rather than assumed.
By physical examination. Pinching the tissue distinguishes graspable fat from loose skin, tensing the neck shows what the platysma is doing, palpation under the jawline identifies gland prominence, and the profile is assessed for chin projection. Most people have a combination, and the proportions decide what is addressed first. This is done in person, not from photographs.
Cooling-based treatments act selectively on fat cells, so if the fold is substantially lax skin, a prominent gland or a slack platysma, the mechanism has nothing to work on. Removing fat from under skin that has lost its recoil can even make the drape more visible. A fold that persists after fat-directed treatment is usually a sign the diagnosis needs revisiting, not that more of the same is needed.
Deoxycholic acid is an injectable that disrupts the membrane of fat cells, causing them to break down; the body then clears the cellular debris. Its mechanism is specific to fat, so it is only relevant where examination confirms the fullness is genuinely a fat compartment, and its suitability, extent and staging are assessed individually at consultation.
It can help where the examination shows the fold is substantially due to skin laxity — energy-based devices work on the collagen support of the skin itself. It does not remove fat, shrink glands or restore muscle tone, so on a genuinely fatty compartment it addresses the envelope rather than the contents. Matching the modality to the responsible tissue is the whole game.
Considerably. A recessed chin shortens the visible jawline and deepens the submental shadow, so modest fullness reads as a fold that a more projected chin would carry invisibly. In such faces, addressing support and structure can matter more than removing anything, and a plan that ignores projection will keep disappointing regardless of how the soft tissue is treated.
Posture does not create fat, glands or laxity, but chin-down positioning compresses the submental tissues, rehearses the fold, and is the exact angle at which front cameras exaggerate it — which is often what triggers the concern. Examination in different head positions separates what is postural and photographic from what is anatomical and persistent.
The submental area is examined by pinch and palpation, the platysma is assessed in activation, the glands are felt for, and the profile is evaluated for chin projection and posture. From that, the responsible tissue or combination is identified and a sequenced plan is discussed, matching each modality to the tissue it actually acts on. Fees are set out at that consultation once the plan is specific.
Jones DH, Carruthers J, Joseph JH, et al. REFINE-1, a phase 3, randomized, double-blind, placebo-controlled trial with ATX-101, an injectable drug for submental fat reduction. Dermatologic Surgery 2016;42(1):38–49. source
The submental area is examined and assessed individually at Orchard Road, Singapore. Consultations by appointment.
WhatsApp +65 8023 7170 →